VEGFA and neoplasm: Similarly, mJAG1 expressed in U87 also instigated tumour resistance to anti-VEGF therapy (Figure 3B) as reflected by the growth delay for 9 days (mJAG1:control versus mJAG1:mAb) compared to the 14-day delay in EV-tumours (EV:control versus EV:mAb).